Area Sales Manager, Central Italy

Overview The Area Sales Manager, Central Italy leads and develops a team of Key Account Managers to deliver sustainable commercial results and improve outcomes for patients. Reporting to the National Sales Director, Italy, this role translates brand and country strategy into effective field execution, strengthens account planning and customer engagement, and provides market insights to inform commercial decisions. The successful candidate will build a high-performing, inclusive team and ensure that all activities are conducted in accordance with applicable laws, industry standards, and Alnylam policies. Key Responsibilities Leadership and Team Development • Lead, coach, and develop a team of Key Account Managers, fostering an inclusive, high-performing culture. • Set clear expectations, provide ongoing feedback, and support employee growth through effective development and succession planning. • Build field capabilities through coaching, product and disease education, and best-practice sharing. Commercial Strategy and Execution • Translate country and brand strategy into territory and account plans that support patient identification and the achievement of commercial objectives. • Drive execution excellence through rigorous account planning, opportunity assessment, and resource prioritization. • Monitor team performance against agreed objectives and key performance indicators, adjusting plans as necessary to maximize results. • Support accurate forecasting and provide actionable market intelligence on customer needs, competitive activity, and healthcare trends. • Drive healthcare professional education initiatives and market development activities in alignment with business objectives. Cross-Functional Collaboration • Partner closely with Medical, Marketing, Market Access, Business Operations, Training, and Country Leadership to ensure aligned execution. • Support the planning and execution of congresses, educational initiatives, sponsorships, and approved commercial activities. • Collaborate with internal stakeholders to establish, monitor, and communicate commercial performance metrics. Compliance and Operational Excellence • Ensure all commercial activities are conducted in compliance with applicable Italian laws, industry codes, company policies, and approved promotional practices. • Promote effective adoption and use of customer relationship management systems and digital tools to support customer engagement, reporting quality, and forecast accuracy. • Ensure timely and accurate documentation, reporting, and communication of field activities. • Ensure pharmacovigilance information and product complaints are reported in accordance with company procedures. Customer Engagement • Build and maintain effective relationships with key healthcare stakeholders and decision-makers. • Accompany team members in the field, as appropriate, to coach customer engagement and strengthen account planning. • Participate directly in strategic customer interactions when required to support business priorities and patient access initiatives.

Qualifications

• Bachelor's degree or equivalent relevant experience. • 5+ years of pharmaceutical, biotechnology, or specialty healthcare commercial experience. • Previous people leadership experience with a track record of coaching and developing field teams. • Strong knowledge of the Italian healthcare environment. • Experience in account planning, forecasting, and performance management. • Fluency in Italian and professional proficiency in English. • Willingness to travel extensively within Italy. Preferred qualifications • Experience in rare diseases, specialty care, or hospital-based products. • Product launch experience. • Experience with Veeva or similar CRM platforms. #LI-LR1 #LI-REMOTE About Alnylam: Alnylam Pharmaceuticals (Nasdaq: ALNY) has led the translation of RNA interference (RNAi) into a whole new class of innovative medicines with the potential to transform the lives of people afflicted with rare and more prevalent diseases. Based on Nobel Prize-winning science, RNAi therapeutics represent a powerful, clinically validated approach to treating diseases at their genetic source by “interfering” with mRNA that cause or contribute to disease. Since our founding in 2002, Alnylam has led the RNAi Revolution and continues to turn scientific possibility into reality. Our culture: Our people-first culture is guided by our core values: fiercely innovative, open culture, purposeful urgency, passion for excellence, and commitment to people, and these values influence how we work and the business decisions we make. Thanks to feedback from our employees over the years, we’ve been fortunate to be named a top employer around the world. Alnylam is extremely proud to have been recognized as one of Science Magazine’s Top Biopharma Employers, one of America's Most Responsible Companies for 2024 by Newsweek, a Fast Company Best Workplace for Innovators, and a Great Place to Work in Canada, France, Italy, Spain, Switzerland, and UK – among others. At Alnylam, we commit to an inclusive recruitment process and equal employment opportunity. We are dedicated to building an environment where employees can feel that they belong, can bring their authentic selves to work, and achieve to their full potential. By empowering employees to embrace their unique differences at work, our business grows stronger with advanced and original thinking, allowing us to bring groundbreaking medicines to patients. Before applying, please review Alnylam's ⁠Candidate Privacy Notice regarding how Alnylam handles Personal Data you provide with your application for employment. The pay range below reflects the full-time base salary range we expect to pay for this role at the time of posting. Base pay will be determined based on a number of factors including, but not limited to, relevant experience, skills and education. This role is eligible for an annual short-term incentive award (e.g. bonus or sales incentive), an annual long-term incentive award (e.g. equity) and competitive benefits. Italy Pay Range €97.800 — €132.300 EUR